STATEMENTS OF EXPENSES (USD $)	3 Months Ended		6 Months Ended		113 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012
Research and development	$ 1,558,208	$ 854,208	$ 3,048,305	$ 1,539,369	$ 73,227,180
General and administrative	529,566	560,834	1,345,762	1,152,892	28,954,837
Depreciation and amortization	76,496	70,732	143,851	100,366	1,490,332
Loss on disposal of assets					510,248
Operating loss	(2,164,270)	(1,485,774)	(4,537,918)	(2,792,627)	(104,182,597)
Interest income	59	260	195	471	1,358,612
Other income, net					661,146
Gain on extinguishment of debt					1,612,440
Gain on derivative instruments					1,388,848
Gain on sale of technology					3,000,000
Interest expense	(486)	(870)	(973)	(2,005)	(9,057,932)
Net loss	$ (2,164,697)	$ (1,486,384)	$ (4,538,696)	$ (2,794,161)	$ (105,219,483)
Basic and diluted loss per share	$ (0.09)	$ (0.06)	$ (0.20)	$ (0.13)
Weighted average shares outstanding	23,048,488	23,048,488	23,048,488	22,007,955